Medline Convenience Kits Recall Over Endotoxin Levels in Neurosponges
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 246 medical convenience kits due to potential out-of-specification endotoxin levels in included Pilling Wecksorb Neurosponges.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on September 10, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Specific item(s) and lot(s) of Medline convenience kits containing Pilling Wecksorb Neurosponges and Neurosponge Strips are being recalled due to potential out-of-specification levels of endotoxin of the neurosponges.", distributed us nationwide distribution in the states of az, ca, ia, id, il, in, ma, md, mi, mn, mo, mt, ny, oh, tx, wi, wy.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP is recalling specific lots of Medline medical convenience kits because they contain Pilling Wecksorb Neurosponges and Neurosponge Strips with potential out-of-specification levels of endotoxin.
Which Products Are Affected
The recall covers 246 kits distributed nationwide in AZ, CA, IA, ID, IL, IN, MA, MD, MI, MN, MO, MT, NY, OH, TX, WI, and WY. Affected products include:
- CRANIOTOMY PACK, Medline Kit SKU DYNJT6545, Lot Numbers 25JMG396 and 26AMH848
- ORTHO SPINE PACK, Medline Kit SKU DYNJ88056A, Lot Number 25FMD894
- ENT SINUS PACK, Medline Kit SKU DYNJ89001, Lot Numbers 25JMH786, 25KMF523, 25KMF530, and 26CMD479
- THYROID ENT, Medline Kit SKU DYNJ908641, Lot Numbers 24ABD437, 24ABO388, 23EBA762, 23HBG168, and 23KBW672
UDI and SKU details are provided in the FDA recall notice.
What You Should Do
Consumers should follow instructions provided in the firm's notification regarding the recalled kits.
Why This Matters
The Class II recall involves devices that may cause temporary or reversible adverse health consequences due to elevated endotoxin levels.
Source
FDA recall number Z-2995-2026, initiated July 8, 2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →American Contract Systems Convenience Kits Recall Over Red Rubber Catheter Specifications
FDA · September 10, 2026
GE Medical Portrait Core Services Software V1.1 Recall Over Loss of Patient Monitoring
FDA · September 10, 2026
Dentsply Sirona Capsule Mixer Recall Over Electrical Discharge Risk
FDA · September 10, 2026
Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,183 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.